Article
Behavioral Sciences
Rikuya Yoshimura, Tomohiro Miyasaka, Satoru Funamoto, Takashi Saito, Takaomi C. C. Saido, Masaya Ikegawa, Nobuto Kakuda
Summary: The morphology of senile plaques in APP knock-in mice brain is influenced by the fixative used. Solid forms of senile plaques similar to those found in the brains of AD patients were observed in APP knock-in mice brain treated with formic acid, Davidson's fluid fixative, and Bouin's fluid fixative. A beta 42 was found as cored plaques, while A beta 38 accumulated around A beta 42.
BRAIN AND BEHAVIOR
(2023)
Article
Neurosciences
Wei-hao Li, Lin-hua Gan, Fang-fang Ma, Rui-li Feng, Jiao Wang, Yan-hui Li, Yang-yang Sun, Ya-jiang Wang, Xin Diao, Fei-yang Qian, Tie-qiao Wen
Summary: The study found that Dcf1 is involved in A beta aggregation, and inhibiting Dcf1 expression can reduce A beta deposition, thereby alleviating the decline in cognitive ability and memory loss in AD patients.
JOURNAL OF ALZHEIMERS DISEASE
(2021)
Review
Chemistry, Medicinal
Kundlik Gadhave, Deepak Kumar, Vladimir N. Uversky, Rajanish Giri
Summary: The exact molecular mechanisms associated with Alzheimer's disease remain a mystery, making the utilization of signaling pathways as potential drug targets limited. It is necessary to find correlations and cross-talk between these pathways and establish different therapeutic targets for a better understanding of the biological events responsible for AD-related neurodegeneration. Consideration should be given to the central role of autophagy in AD and its interplay with other pathways as the finest therapeutic strategy.
MEDICINAL RESEARCH REVIEWS
(2021)
Article
Biochemistry & Molecular Biology
Harshitha Santhosh Kumar, James Moore, Adrian C. Steiner, Emmanuel Sotirakis, Benjamin Schaerli, Patricia Isnard-Petit, Kader Thiam, David P. Wolfer, Erik C. Boettger
Summary: This study investigates the role of protein homeostasis in the accumulation of Alzheimer's associated protein A beta and levels of associated Tau phosphorylation. Surprisingly, disruptions in protein homeostasis did not significantly affect A beta accumulation and phosphorylated Tau levels.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Santiago Ramirez, Suelyn Koerich, Natalia Astudillo, Nicole De Gregorio, Rabab Al-Lahham, Tyler Allison, Natalia Pessoa Rocha, Fei Wang, Claudio Soto
Summary: This study aimed to evaluate the effect of removing Aβ from blood plasma on the accumulation of amyloid plaques in the brain. The results showed a reduction in Aβ levels in the plasma and insoluble brain fractions, as well as a decrease in amyloid plaque burden and changes in plaque size distribution in the cortex and hippocampus. These findings support the importance of targeting Aβ in the periphery and suggest plasma exchange as a potential non-pharmacological strategy for slowing down AD pathogenesis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Neurosciences
Jun Zhang, Yixin Chen, Yarui Zhao, Panpan Wang, Hongbin Ding, Cong Liu, Junhong Lyu, Weidong Le
Summary: The study demonstrates that THz wave treatment has significant effects in improving cognitive impairment and alleviating neuropathology in Alzheimer's disease, suggesting its potential as a novel therapeutic intervention.
NEUROSCIENCE BULLETIN
(2023)
Article
Biochemistry & Molecular Biology
Victoria Garcia-Morales, Anabel Gonzalez-Acedo, Lucia Melguizo-Rodriguez, Teresa Pardo-Moreno, Victor Javier Costela-Ruiz, Maria Montiel-Troya, Juan Jose Ramos-Rodriguez
Summary: Alzheimer's disease is characterized by cognitive decline and memory loss, with the amyloid cascade hypothesis being the leading theory in its pathophysiology. Diagnosis is currently based on clinical parameters and fluid-based biomarkers, with treatment focusing on symptom control through pharmacological and nonpharmacological approaches. Further research is needed to identify new biomarkers and therapies to prevent progression of the disease.
Review
Biochemistry & Molecular Biology
Huiqin Zhang, Wei Wei, Ming Zhao, Lina Ma, Xuefan Jiang, Hui Pei, Yu Cao, Hao Li
Summary: Extracellular neuritic plaques and intracellular neurofibrillary tangles, composed of amyloid-beta and phosphorylated tau protein respectively, are hallmark proteins of Alzheimer's disease. The interactions between these proteins have been extensively studied, with A beta accelerating tau phosphorylation, tau mediating A beta toxicity, and potential synergistic effects on microglial cells and astrocytes. Understanding these interactions may lead to new interventions against Alzheimer's disease.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2021)
Article
Neurosciences
Jacob M. Basak, Aura Ferreiro, Lucy S. Cohen, Patrick W. Sheehan, Collin J. Nadarajah, Michael F. Kanan, Kimberley V. Sukhum, Gautam Dantas, Erik S. Musiek
Summary: The study reveals that sepsis may exacerbate amyloid plaque deposition and plaque-related inflammation, potentially leading to increased dementia in older sepsis survivors.
NEUROBIOLOGY OF DISEASE
(2021)
Review
Immunology
Minghui Wang, Hu Zhang, Jiling Liang, Jielun Huang, Ning Chen
Summary: Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by the formation of neurofibrillary tangles and senile plaques. Neuroinflammation, specifically the long-term activation of pro-inflammatory microglia and NLRP3 inflammasomes, plays a crucial role in the development and progression of AD. Exercise has been found to ameliorate AD by regulating the immune response and promoting neurogenesis in the hippocampus.
JOURNAL OF NEUROINFLAMMATION
(2023)
Article
Clinical Neurology
Lei Liu, Hyunchang Kwak, Trebor L. Lawton, Shan-Xue Jin, Angela L. Meunier, Yifan Dang, Beth Ostaszewski, Alison C. Pietras, Andrew M. Stern, Dennis J. Selkoe
Summary: The study developed a new method for detecting and quantifying soluble oligomers of amyloid beta protein in human plasma. The method is highly sensitive, cost-effective, and suitable for high throughput analysis.
ALZHEIMERS & DEMENTIA
(2022)
Review
Biochemistry & Molecular Biology
Karolina Wojtunik-Kulesza, Monika Rudkowska, Anna Orzel-Sajdlowska
Summary: In June 2021, the FDA approved a new drug for Alzheimer's disease called Aducanumab. This monoclonal antibody IgG1 targets amyloid beta, a main cause of Alzheimer's disease. Clinical trials have shown that Aducanumab can reduce amyloid beta and improve cognition. However, there is controversy surrounding its limitations, costs, and side effects. This review focuses on the mechanism of action of Aducanumab and discusses both the positive and negative aspects of the therapy.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Clinical Neurology
Lei Liu, Bianca M. Lauro, Amy He, Hyo Lee, Sanjay Bhattarai, Michael S. Wolfe, David A. Bennett, Celeste M. Karch, Tracy Young-Pearse, Dennis J. Selkoe
Summary: This study aims to identify biomarkers for Alzheimer's disease (AD) and finds that the A beta 37/42 ratio can be used to distinguish AD from normal aging. Experimental results show that this ratio outperforms the traditional ratio in differentiating physiological and pathological states in cell culture, brain tissue, and cerebrospinal fluid. The findings may provide a new indicator for early diagnosis of AD.
ALZHEIMERS & DEMENTIA
(2023)
Review
Biochemistry & Molecular Biology
Chen Ma, Fenfang Hong, Shulong Yang
Summary: This review provides an overview of the amyloid hypothesis of Alzheimer's disease, emphasizing the key role of amyloid beta protein in AD. The review also discusses the process of amyloid formation, autophagy, cerebral blood flow, and the detailed pathogenesis of amyloidosis.
Review
Biochemistry & Molecular Biology
Pasquale Picone, Tiziana Sanfilippo, Sonya Vasto, Sara Baldassano, Rossella Guggino, Domenico Nuzzo, Donatella Bulone, Pier Luigi San Biagio, Emanuela Muscolino, Roberto Monastero, Clelia Dispenza, Daniela Giacomazza
Summary: Alzheimer's disease is the most common neurodegenerative disorder in the elderly, characterized by senile plaques and neurofibrillary tangles. There is currently a lack of treatment options aside from symptomatic medications. This review presents research results on the use of peptides of different sizes for the treatment of Alzheimer's disease.
Article
Chemistry, Multidisciplinary
Leila Josefsson, Xinchen Ye, Calvin J. Brett, Vjonas Meijer, Carl Olsson, Amanda Sjogren, Josefin Sundlof, Anton Davydok, Maud Langton, Asa Emmer, Christofer Lendel
ACS SUSTAINABLE CHEMISTRY & ENGINEERING
(2020)
Article
Biochemistry & Molecular Biology
Himanshu Chaudhary, Sebastian W. Meister, Henrik Zetterberg, John Lofblom, Christofer Lendel
ACS CHEMICAL NEUROSCIENCE
(2020)
Article
Chemistry, Multidisciplinary
Xinchen Ye, Antonio J. Capezza, Xiong Xiao, Christofer Lendel, Mikael S. Hedenqvist, Vadim G. Kessler, Richard T. Olsson
Summary: Protein nanofibrils (PNFs) were prepared by whey protein fibrillation at low pH and in the presence of different metal ions. The metal ions' valence state and ionic radius significantly influenced the gelation behavior and fibrillation kinetics of the PNFs, with higher valence states and smaller ionic radii resulting in faster hydrogel formation. The presence of metal ions also affected the viscoelastic properties of the hydrogels, with more acidic metal ions inducing higher storage modulus compared to less acidic ones.
Article
Biochemistry & Molecular Biology
M. Mahafuzur Rahman, Benjamin Schmuck, Henrik Hansson, Torleif Hard, Gunilla T. Westermark, Mats Sandgren
Summary: A new method using functionalized protein nanofibrils for enhanced ATTR amyloid detection has been developed, allowing sensitive detection of small ATTR deposits at an early stage of the disease.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
(2021)
Article
Green & Sustainable Science & Technology
Xinchen Ye, Antonio J. Capezza, Vasantha Gowda, Richard T. Olsson, Christofer Lendel, Mikael S. Hedenqvist
Summary: Covalently crosslinked protein networks from whey protein nanofibrils exhibit sustainable high-performance as foams, with excellent chemical resistance and mechanical strength even at high temperatures. By adding plasticizers, the mechanical performance of the foams is improved significantly, making them suitable for harsh environments.
ADVANCED SUSTAINABLE SYSTEMS
(2021)
Article
Multidisciplinary Sciences
M. Mahafuzur Rahman, Rodrigo Sanches Pires, Anja Herneke, Vasantha Gowda, Maud Langton, Henrik Biverstal, Christofer Lendel
Summary: The deposition of proteins in the form of amyloid fibrils is associated with serious diseases. However, the process triggering the conversion into insoluble amyloid is not fully understood. This study investigates the cross-seeding of amyloid-beta (A beta) by amyloid fibrils derived from food proteins or peptides, and the results suggest that food-derived amyloid is not a risk factor for the development of A beta pathology and Alzheimer's disease.
SCIENTIFIC REPORTS
(2023)
Article
Food Science & Technology
Anja Herneke, Christofer Lendel, Saeid Karkehabadi, Jing Lu, Maud Langton
Summary: This study investigated the formation of protein nanofibrils (PNFs) from whole fava bean protein and its two major storage proteins (11S and 7S). The results showed that heat-incubated proteins formed straight semi-flexible PNFs, with the smaller 7S protein being superior to 11S. The fibrillated protein from fava bean, 11S, and 7S improved foam properties at a concentration of 10 mg/mL.
Article
Chemistry, Applied
Anja Herneke, Saeid Karkehabadi, Jing Lu, Christofer Lendel, Maud Langton
Summary: In this study, protein nanofibrils (PNFs) were generated from mung bean protein isolate and its globular 8S fraction, and their properties were investigated under different pH conditions. It was found that PNFs at pH 4-8 exhibited good foaming properties. This study provides valuable insights into the structure and foaming properties of PNFs, which can potentially be utilized in innovative food applications.
FOOD HYDROCOLLOIDS
(2023)
Review
Chemistry, Multidisciplinary
Christofer Lendel, Niclas Solin
Summary: The development towards a sustainable society requires radical changes in the materials we use, with proteins playing important roles in applications such as green energy and environmental remediation. Protein nanofibrils (PNFs) formed by self-assembly in water have the potential to create ordered functional structures, bridging the gap between atomic and macroscopic scales. Understanding the assembly of PNFs from industrial scale protein resources and modifying their properties could lead to materials with specific mechanical and functional properties.
Article
Chemistry, Multidisciplinary
Vasantha Gowda, Michal Biler, Andrei Filippov, Malisa Mantonico, Eirini Ornithopoulou, Mathieu Linares, Oleg N. Antzutkin, Christofer Lendel
Summary: This study investigated the nanoscale morphology and molecular arrangement of amyloid-like PNFs of a synthetic peptide consisting of residues 11-20 of beta-lactoglobulin. The presence of polymorphic self-assembly of protofilaments at the nanoscale was observed, while NMR data suggested that the observed polymorphism originated from the assembly of protofilaments but not from the molecular structure. The peptides were found to form parallel beta-sheets, with molecular dynamics simulations confirming the stability of parallel beta-sheets and suggesting two possible modes of packing.
Article
Food Science & Technology
Anja Herneke, Christofer Lendel, Daniel Johansson, William Newson, Mikael Hedenqvist, Saeid Karkehabadi, David Jonsson, Maud Langton
Summary: Plant-based protein nanofibrils (PNFs) have been shown to have the potential for use in sustainable food applications and biobased materials. Different plant proteins were found to be able to form PNFs under acidic and heat conditions, with unique features and morphological alterations observed. Purification of the fibril-forming protein component can enhance PNF production for future scaled-up applications.
ACS FOOD SCIENCE & TECHNOLOGY
(2021)
Article
Chemistry, Multidisciplinary
Leila Josefsson, Melker Cronhamn, Malin Ekman, Hugo Widehammar, Asa Emmer, Christofer Lendel
Article
Immunology
Sophia Hober, Cecilia Hellstrom, Jennie Olofsson, Eni Andersson, Sofia Bergstrom, August Jernbom Falk, Shaghayegh Bayati, Sara Mravinacova, Ronald Sjoberg, Jamil Yousef, Lovisa Skoglund, Sara Kanje, Anna Berling, Anne-Sophie Svensson, Gabriella Jensen, Henric Enstedt, Delaram Afshari, Lan Lan Xu, Martin Zwahlen, Kalle von Feilitzen, Leo Hanke, Ben Murrell, Gerald McInerney, Gunilla B. Karlsson Hedestam, Christofer Lendel, Robert G. Roth, Ingmar Skoog, Elisabet Svenungsson, Tomas Olsson, Anna Fogdell-Hahn, Ylva Lindroth, Maria Lundgren, Kimia T. Maleki, Nina Lagerqvist, Jonas Klingstrom, Rui Da Silva Rodrigues, Sandra Muschiol, Gordana Bogdanovic, Laila Sara Arroyo Muhr, Carina Eklund, Camilla Lagheden, Joakim Dillner, Asa Sivertsson, Sebastian Havervall, Charlotte Thalin, Hanna Tegel, Elisa Pin, Anna Manberg, My Hedhammar, Peter Nilsson
Summary: A high-throughput multiplex bead-based serological assay was developed and validated, using three selected antigens with high sensitivity and specificity. The best assay performance was achieved with a combination of two antigens, providing a sensitivity of 99.7% and a specificity of 100%.
CLINICAL & TRANSLATIONAL IMMUNOLOGY
(2021)